Researchers in Lithuania have made a groundbreaking discovery that could potentially change the lives of millions living with osteoarthritis. A new study published in Scientific Reports reveals that tiny particles from menstrual blood, known as extracellular vesicles (EVs), can help repair damaged cartilage. This breakthrough is especially significant given that current treatments for osteoarthritis only provide symptom relief without addressing the underlying disease pathology. According to Dr. Mohit Kapoor, co-director of UHN’s Schroeder Arthritis Institute, there are no approved disease-modifying therapies for the treatment of osteoarthritis, making this research a promising development.
Context
Osteoarthritis affects over 600 million people worldwide, causing joint pain, stiffness, and limited mobility. The condition is characterized by the breakdown of cartilage, which acts as a cushion between bones. Current treatments, such as pain relief medications and joint replacement surgery, do not address the root cause of the disease. The lack of effective treatments has led to a significant unmet need for innovative therapies that can repair or replace damaged cartilage.
Background Information
The study published in Scientific Reports is based on research conducted by a team of scientists in Lithuania, who investigated the potential of menstrual blood-derived EVs (MenSC-EVs) to repair damaged cartilage. The researchers collected menstrual blood from healthy donors and isolated the EVs, which were then tested on cartilage samples from women with osteoarthritis. The results showed that the MenSC-EVs stimulated cartilage cells called chondrocytes and promoted cartilage matrix production, effectively nudging damaged cartilage cells to start rebuilding.
Main Body
The study’s findings are significant, as they demonstrate the potential of MenSC-EVs to repair damaged cartilage. The researchers found that the EVs boosted extracellular matrix (ECM) production, which is the structural
